Core Insights - Celsior Technologies has joined the Jack Henry Fintech Integration Network (FIN), enabling integration with Jack Henry's core platforms to enhance digital transformation for regulated industries [1][2][3] Company Overview - Celsior Technologies specializes in providing technology and workforce solutions aimed at digital transformation, particularly for financial services [1][6] - The company focuses on delivering customized, outcome-driven technology solutions that optimize operations and drive digital transformation [6] Integration and Collaboration - Through FIN, Celsior can help banks modernize digital workflows, improve operational efficiency, and accelerate technology initiatives that comply with regulatory and security standards [3][4] - The integration with Jack Henry's core platform via jXchange™ allows for secure access to core data and business rules, ensuring data integrity and consistent data exchange [2][3] Strategic Benefits - Celsior's participation in FIN strengthens its capability to provide secure, scalable, and integration-ready technology solutions to financial institutions [4] - The collaboration allows Celsior to work closely with Jack Henry customers, enhancing their platform modernization and improving customer and operational experiences [4]

Core Viewpoint - S&P Global will participate in Raymond James' 47th Annual Institutional Investors Conference on March 3, 2026, where key executives will discuss the company's strategies and outlook [1]. Group 1: Event Details - Martina Cheung, President and CEO, and Eric Aboaf, CFO, will speak from 11:00 a.m. to 11:30 a.m. (Eastern Time) [1]. - The session will be webcast live and will include forward-looking information [1]. - A replay of the webcast will be available within 24 hours and accessible for 90 days, ending on May 31, 2026 [1]. Group 2: Company Overview - S&P Global provides trusted data, expertise, and technology to help businesses, governments, and individuals make informed decisions [1]. - The company focuses on advancing essential intelligence through benchmarks, data, and insights necessary for economic planning and decision-making [1]. - S&P Global supports clients in assessing investments across various markets and navigating challenges in energy, artificial intelligence, and market evolution [1].

Core Viewpoint - Abbott has declared its 409th consecutive quarterly dividend of 63 cents per share, highlighting its long-standing commitment to returning value to shareholders and its status as a member of the S&P 500 Dividend Aristocrats Index [1][1]. Group 1: Dividend Information - The quarterly common dividend of 63 cents per share is payable on May 15, 2026, to shareholders of record as of April 15, 2026 [1]. - Abbott has increased its dividend payout for 54 consecutive years, demonstrating consistent growth in shareholder returns [1]. Group 2: Company Overview - Abbott is a global healthcare leader with a diverse portfolio that includes diagnostics, medical devices, nutritionals, and branded generic medicines [1]. - The company employs approximately 115,000 colleagues and serves customers in over 160 countries [1].

Core Viewpoint - The Allstate Corporation has declared approximately $29.3 million in aggregate dividends on three series of preferred stock for the period from January 15, 2026, to April 14, 2026, with payments scheduled for April 15, 2026 [1]. Dividend Information - The preferred dividends are payable in cash to stockholders of record as of March 31, 2026, with the following details: - Series H: Annual Dividend Rate of 5.100%, Quarterly Amount of $0.3187500 per depositary share - Series I: Annual Dividend Rate of 4.750%, Quarterly Amount of $0.2968750 per depositary share - Series J: Annual Dividend Rate of 7.375%, Quarterly Amount of $0.4609375 per depositary share [1]. Company Overview - The Allstate Corporation provides protection against life's uncertainties through affordable and connected protection products for autos, homes, electronic devices, and identities, distributed via a broad network including Allstate agents, independent agents, major retailers, online platforms, and workplaces [1]. - The company has 211 million policies in force and is recognized for its slogan "You're in Good Hands with Allstate" [1].

Core Viewpoint - CoreWeave, Inc. is facing a securities class action lawsuit alleging that the company misled investors about its ability to scale its AI infrastructure and meet revenue guidance, leading to significant financial losses for shareholders [1][1]. Group 1: Allegations and Impact - The lawsuit claims that CoreWeave overstated its capacity to meet customer demand and concealed operational risks associated with reliance on a single third-party data center supplier [1][1]. - Following the revelation of delays at a critical data center in Denton, Texas, CoreWeave's market capitalization dropped by approximately $14 billion [1][1]. - The company experienced a 16% stock price decline on November 11 after lowering its revenue guidance, contributing to a series of stock drops that resulted in billions in lost shareholder value [1][1]. Group 2: Operational Concerns - Plaintiffs allege that CoreWeave's ability to recognize revenue from its multibillion-dollar backlog was dependent on infrastructure that management was aware was not on track for timely completion [1][1]. - The complaint highlights that CoreWeave downplayed significant delays at its Denton facility, contradicting management's claims of "rapid scaling" [1][1]. - A Wall Street Journal report indicated that the completion of the Denton facility had been delayed by several months due to severe construction hurdles [1][1]. Group 3: Legal Proceedings - Hagens Berman, the law firm representing the plaintiffs, is actively advising investors who purchased CoreWeave shares during the class period from March 28, 2025, to December 15, 2025, and suffered losses [1][1]. - The deadline for lead plaintiffs to submit their claims is set for March 13, 2026 [1][1].

Core Insights - Zions Bancorporation has been awarded 15 Best Bank Awards by Coalition Greenwich for 2026, recognizing its service to middle market and small business clients [1][3] - The bank has consistently averaged 15 or more awards annually since the inception of the awards in 2009, making it one of only four U.S. banks to achieve this [1][3] - Zions Bancorporation has received a total of 261 awards from Coalition Greenwich over 17 years [3] Awards and Recognition - The awards are based on approximately 25,000 market research interviews with businesses, evaluating over 500 banks, with 46 recognized for distinctive quality [2] - Zions received awards in various categories, including Best Bank for Trust, Customer Service, and Advisory Capabilities [4][9] - Specific categories of recognition include Middle Market ($10-$500 million in annual sales) and Small Business ($1-$10 million in annual sales) [5][6] Company Overview - As of December 31, 2025, Zions Bancorporation has approximately $89 billion in total assets and annual net revenue of $3.4 billion for 2025 [7] - The bank operates under local management teams and distinct brands across 11 western states, including Arizona, California, and Texas [7] - Zions is recognized as a leader in public finance advisory services and Small Business Administration lending, and is included in the S&P MidCap 400 and NASDAQ Financial 100 indices [7]

PMI SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026 [Accessibility Statement] Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner [James (Josh) Wilson] Encourages Investors Who Suffered Losses Exceeding $50,000 In Picard Medical To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in [Picard Medical] between September 2, 2025 and October 31, 2025 and would like to ...

PYPL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds PayPal (PYPL) Investors of Securities Class Action Deadline on April 20, 2026 [Accessibility Statement] Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner [James (Josh) Wilson] Encourages Investors Who Suffered Losses Exceeding $50,000 In PayPal To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in [PayPal] between February 25, 2025 and February 2, 2026 and would like to discuss your legal rig ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against uniQure N.V. and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action filed against the company [1] Group 1: Allegations Against uniQure - The complaint alleges that uniQure and its executives violated federal securities laws by making false and/or misleading statements and failing to disclose that the design of uniQure's Pivotal Study was not fully approved by the FDA [1] - Defendants downplayed the likelihood that uniQure would have to delay its Biologics License Application (BLA) timeline to perform additional studies, despite purportedly successful results from the Pivotal Study [1] - As a result, the statements made by Defendants regarding the company's business, operations, and prospects lacked a reasonable basis [1] Group 2: Impact of FDA Disclosure - On November 3, 2025, uniQure disclosed that the FDA "currently no longer agrees" that data from the Phase I/II AMT-130 studies would be adequate to support a BLA submission [1] - The company admitted that the timing of any BLA submission for AMT-130 was now unclear, revealing the falsity of prior representations that AMT-130 was on a near-term path toward accelerated approval [1] - Following this disclosure, uniQure's ordinary share price fell by $33.40 per share, or more than 49%, from a close of $67.69 on October 31, 2025, to $34.29 on November 3, 2025 [1]

ARDT SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ardent Health (ARDT) Investors of Securities Class Action Deadline on March 9, 2026 [Accessibility Statement] Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner [James (Josh) Wilson] Encourages Investors Who Suffered Losses Exceeding $50,000 In Ardent To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in [Ardent] between July 18, 2024 and November 12, 2025 and would like to discuss your legal ...